Washington Administrative Code
Title 182 - Health Care Authority
WASHINGTON APPLE HEALTH
Chapter 182-530 - Prescription drugs (outpatient)
AUTHORIZATION
Section 182-530-3100 - How the medicaid agency determines when a drug requires authorization

Universal Citation: WA Admin Code 182-530-3100

Current through Register Vol. 24-18, September 15, 2024

(1) The medic-aid agency's pharmacists or medical consultants periodically evaluate covered drugs, covered indications, or new dosages approved by the Food and Drug Administration (FDA) to determine the drug authorization requirement.

(a) The clinical team evaluates and grades available information for each drug or drug class based on quality evidence contained in compendia of drug information and peer-reviewed medical literature. The information evaluated includes, but is not limited to:
(i) Evidence for efficacy and safety;

(ii) Cost comparisons of drugs with similar existing drugs;

(iii) Potential for clinical misuse;

(iv) Potential for client misuse or abuse;

(v) Drugs with a narrow therapeutic index;

(vi) Other safety concerns; or

(vii) Product cost and outcome data demonstrating the cost effectiveness of the drug, device, or drug-related supply.

(b) In performing this evaluation the clinical team may consult with other agency clinical staff, financial experts, and program managers. The agency clinical team may also consult with an evidence-based practice center (EPC), evidence-based drug reviews, other purchasers, the drug use review (DUR) board, and medical experts in this evaluation.

(c) Based on the clinical team's evaluation , the agency may determine that the drug, device, or drug-related supply:
(i) Requires authorization;

(ii) Requires authorization to exceed agency-established limitations; or

(iii) Does not require authorization.

(2) The agency periodically reviews existing drugs, devices, or drug-related supplies and reassigns authorization requirements as necessary according to the same provisions as outlined above for new drugs, devices, or pharmaceutical supplies.

(3) For any drug, device, or drug-related supply with limitations or requiring authorization, the agency may elect to apply automated authorization criteria according to WAC 182-530-3200.

11-14-075, recodified as §182-530-3100, filed 6/30/11, effective 7/1/11. Statutory Authority: RCW 74.04.050, 74.08.090, 74.09.530, and 74.09.700. 07-20-049, § 388-530-3100, filed 9/26/07, effective 11/1/07.

Disclaimer: These regulations may not be the most recent version. Washington may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.